会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Physiologically active peptide and its use
    • 生理活性肽及其用途
    • US07064181B1
    • 2006-06-20
    • US09646078
    • 1999-03-24
    • Tetsuya OhtakiHideki MatsuiYoshihiro IshibashiKazuhiro OgiChieko Kitada
    • Tetsuya OhtakiHideki MatsuiYoshihiro IshibashiKazuhiro OgiChieko Kitada
    • C07K14/00
    • C07K16/18A61K38/00C07K14/47C07K14/705C07K14/72
    • The present invention relates to a peptide comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 35 and having an ability of binding to a receptor protein comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a precursor thereof, its amide or ester, or a salt thereof.An inventive peptide-encoding DNA or equivalent can be employed in (1) a development of a receptor binding assay system using an expression system of a recombinant receptor protein and a screening for a pharmaceutical candidate compound, and (2) a development of a pharmaceutical having a reduced side effect such as a memory function improving agent, a appetite improving agent, an uterine, renal, prostatic, testicular or skeletal muscle function regulating agent.
    • 本发明涉及一种肽,其包含与SEQ ID NO:35所示的氨基酸序列相同或基本相同的氨基酸序列,并且具有与受体蛋白结合的能力,所述受体蛋白包含与 由SEQ ID NO:1,SEQ ID NO:2或SEQ ID NO:3表示的氨基酸序列,或其前体,其酰胺或酯或其盐。 本发明的编码编码DNA的DNA或等同物可以用于(1)使用重组受体蛋白质的表达系统和药物候选化合物的筛选的受体结合测定系统的开发,和(2)药物 具有减少的副作用,例如记忆功能改善剂,食欲改善剂,子宫,肾,前列腺,睾丸或骨骼肌功能调节剂。
    • 4. 发明授权
    • DNA encoding galanin receptor activating peptide
    • 编码甘丙肽受体激活肽的DNA
    • US07374910B2
    • 2008-05-20
    • US11376694
    • 2006-03-15
    • Tetsuya OhtakiHideki MatsuiYoshihiro IshibashiKazuhiro OgiChieko Kitada
    • Tetsuya OhtakiHideki MatsuiYoshihiro IshibashiKazuhiro OgiChieko Kitada
    • C01N15/11C01N15/63C01N5/10
    • C07K16/18A61K38/00C07K14/47C07K14/705C07K14/72
    • The present invention relates to a peptide comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 35 and having an ability of binding to a receptor protein comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a precursor thereof, its amide or ester, or a salt thereof.An inventive peptide-encoding DNA or equivalent can be employed in (1) a development of a receptor binding assay system using an expression system of a recombinant receptor protein and a screening for a pharmaceutical candidate compound, and (2) a development of a pharmaceutical having a reduced side effect such as a memory function improving agent, an appetite improving agent, an uterine, renal, prostatic, testicular or skeletal muscle function regulating agent.
    • 本发明涉及一种肽,其包含与SEQ ID NO:35所示的氨基酸序列相同或基本相同的氨基酸序列,并且具有与受体蛋白结合的能力,所述受体蛋白包含与 由SEQ ID NO:1,SEQ ID NO:2或SEQ ID NO:3表示的氨基酸序列,或其前体,其酰胺或酯或其盐。 本发明的编码编码DNA的DNA或等同物可以用于(1)使用重组受体蛋白质的表达系统和药物候选化合物的筛选的受体结合测定系统的开发,和(2)药物 具有减少的副作用,例如记忆功能改善剂,食欲改善剂,子宫,肾,前列腺,睾丸或骨骼肌功能调节剂。
    • 5. 发明申请
    • Novel physiologically active peptide and its use
    • 新型生理活性肽及其用途
    • US20060155109A1
    • 2006-07-13
    • US11376694
    • 2006-03-15
    • Tetsuya OhtakiHideki MatsuiYoshihiro IshibashiKazuhiro OgiChieko Kitada
    • Tetsuya OhtakiHideki MatsuiYoshihiro IshibashiKazuhiro OgiChieko Kitada
    • A61K38/22C07K14/575
    • C07K16/18A61K38/00C07K14/47C07K14/705C07K14/72
    • The present invention relates to a peptide comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 35 and having an ability of binding to a receptor protein comprising an amino acid sequence identical to or substantially identical to an amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3, or a precursor thereof, its amide or ester, or a salt thereof. An inventive peptide-encoding DNA or equivalent can be employed in (1) a development of a receptor binding assay system using an expression system of a recombinant receptor protein and a screening for a pharmaceutical candidate compound, and (2) a development of a pharmaceutical having a reduced side effect such as a memory function improving agent, an appetite improving agent, an uterine, renal, prostatic, testicular or skeletal muscle function regulating agent.
    • 本发明涉及一种肽,其包含与SEQ ID NO:35所示的氨基酸序列相同或基本相同的氨基酸序列,并且具有与受体蛋白结合的能力,所述受体蛋白包含与 由SEQ ID NO:1,SEQ ID NO:2或SEQ ID NO:3表示的氨基酸序列,或其前体,其酰胺或酯或其盐。 本发明的编码编码DNA的DNA或等同物可以用于(1)使用重组受体蛋白质的表达系统和药物候选化合物的筛选的受体结合测定系统的开发,和(2)药物 具有减少的副作用,例如记忆功能改善剂,食欲改善剂,子宫,肾,前列腺,睾丸或骨骼肌功能调节剂。
    • 9. 发明授权
    • Polypeptides, their production and use
    • 多肽,其生产和使用
    • US06881545B1
    • 2005-04-19
    • US09716147
    • 2000-11-17
    • Shuji HinumaYugo HabataYuji KawamataMasaki HosoyaRyo FujiiShoji FukusumiChieko Kitada
    • Shuji HinumaYugo HabataYuji KawamataMasaki HosoyaRyo FujiiShoji FukusumiChieko Kitada
    • C07K14/575C07K14/705G01N33/53C07K7/08C07K14/72
    • C07K14/705C07K14/575
    • The present invention relates to the ligand polypeptide for the human pituitary- and mouse pancreas-derived G protein-coupled receptor proteins.The ligand polypeptide or the DNA which codes for the ligand polypeptide can be used for (1) development of medicines such as pituitary function modulators, central nervious system function modulators, and pancreatic function modulators, and (2) development of receptor binding assay systems using the expression of recombinant receptor proteins and screening of pharmaceutical candidate compounds.In particular, by the receptor binding assay systems utilizing the expression of recombinant G protein-coupled receptor proteins in accordance with the invention, agonists and antagonists of G protein-coupled receptors which are specific to human and other warm-blooded animals can be screened and the agonists or antagonists obtained can be used as therapeutic and prophylactic agents for various diseases.
    • 本发明涉及用于人垂体和小鼠胰腺衍生的G蛋白偶联受体蛋白质的配体多肽。 编码配体多肽的配体多肽或DNA可用于(1)开发药物,例如垂体功能调节剂,中枢神经系统功能调节剂和胰功能调节剂,以及(2)开发受体结合测定系统,其使用 重组受体蛋白的表达和药物候选化合物的筛选。 特别地,通过利用根据本发明的重组G蛋白偶联受体蛋白表达的受体结合测定系统,可以筛选对人类和其他温血动物特异性的G蛋白偶联受体的激动剂和拮抗剂, 获得的激动剂或拮抗剂可用作各种疾病的治疗和预防剂。